TIM-2 is expressed on B cells and in liver and kidney and is a receptor for H-ferritin endocytosis

Veterans Administration Medical Center, San Francisco, CA 94121, USA.
Journal of Experimental Medicine (Impact Factor: 13.91). 11/2005; 202(7):955-65. DOI: 10.1084/jem.20042433
Source: PubMed

ABSTRACT T cell immunoglobulin-domain and mucin-domain (TIM) proteins constitute a receptor family that was identified first on kidney and liver cells; recently it was also shown to be expressed on T cells. TIM-1 and -3 receptors denote different subsets of T cells and have distinct regulatory effects on T cell function. Ferritin is a spherical protein complex that is formed by 24 subunits of H- and L-ferritin. Ferritin stores iron atoms intracellularly, but it also circulates. H-ferritin, but not L-ferritin, shows saturable binding to subsets of human T and B cells, and its expression is increased in response to inflammation. We demonstrate that mouse TIM-2 is expressed on all splenic B cells, with increased levels on germinal center B cells. TIM-2 also is expressed in the liver, especially in bile duct epithelial cells, and in renal tubule cells. We further demonstrate that TIM-2 is a receptor for H-ferritin, but not for L-ferritin, and expression of TIM-2 permits the cellular uptake of H-ferritin into endosomes. This is the first identification of a receptor for ferritin and reveals a new role for TIM-2.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The kinetics of dietary iron-import into various organs of mice were evaluated using a novel pup swapping approach. Newborn pups whose bodies primarily contained 56Fe or 57Fe were swapped at birth such that each nursed on milk containing the opposite isotope. A pup from each litter was euthanized weekly over a 7 wk period. Blood plasma was obtained and organs were isolated typically after flushing with Ringers buffer. 56Fe and 57Fe concentrations were determined for organs and plasma; organ volumes were also determined. Mossbauer spectra of equivalent 57Fe-enriched samples were used to quantify residual blood in organs; this fraction was excluded from later analysis. Rates of import into brain, spleen, heart and kidneys were highest during the first 2 wks of life. In contrast, half of the Fe in the newborn liver exited during that time and influx peaked later. Two mathematical models were developed to analyze the import kinetics. The only one that simulated the data adequately assumed that an Fe-containing species enters the plasma and converts into a second species, and that both are independently imported into organs. Consistent with this, liquid chromatography with an on-line ICP-MS detector revealed numerous Fe species in plasma besides transferrin. Model fitting required that the first species, assigned to non-transferrin-bound iron (NTBI), import faster into organs than the second, assigned to transferrin-bound-iron (TBI). NTBI rather than TBI appears to play the dominant role in importing Fe into organs during early development of healthy mice.
    Journal of Biological Chemistry 11/2014; 290(1). DOI:10.1074/jbc.M114.606731 · 4.60 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Ferritin has a key role in Adult-onset Still's disease (AOSD). Its production seems related to macrophage activation of which sCD163 is a major serum marker. Thus, we aimed at evaluating the role of sCD163 in AOSD and its relationship with ferritin. Furthermore, we determined the expression of CD163 and ferritin in a lymph-node from an AOSD patient. sCD163 and serum ferritin were measured in 34 patients with AOSD (21 active, 13 non-active), 18 sepsis and 22 healthy controls (HC). Immunohistology was performed on a lymph-node from an AOSD patient in order to detect CD163 and ferritin. A tonsil from an HC was used as control. Mean sCD163 (8.6 ± 5.4 mg/L) was higher in active AOSD than "non-active" patients (4.6 ± 2.7 mg/L, p = 0.02). The mean sCD163 in AOSD (6.9 ± 4.9 mg/L) and sepsis (7.1 ± 5.6 mg/L) were higher than in HC (2.56 ± 1.17 mg/L, p < 0.001), but no difference between AOSD and sepsis was detected. sCD163 positively correlated with ferritin (p = 0.0045; r = 0.4755) only in AOSD. Serum ferritin (mean 3,640.1 ± 6,896.9 µg/L) was higher in active AOSD than in sepsis (1,720.2 ± 3,882.1 µg/L, p < 0.007). CD163 was equally distributed in the B and T areas of both lymph-node and tonsil. Differently from the tonsil, ferritin was expressed only in the lymph-node B area. sCD163 is a marker of disease activity in AOSD. The correlation with ferritin may lead to hypothesize a macrophage activation related to hyperferritinemia. Ferritin was found expressed only in the B area of the AOSD lymph-node, suggesting a role for this molecule as an antigen in the disease pathogenesis.
    Immunologic Research 11/2014; 60(2-3). DOI:10.1007/s12026-014-8563-7 · 3.53 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Iron is essential in the retina because the heme-containing enzyme guanylate cyclase modulates phototransduction in rods and cones. Transferrin endocytosis is the classical pathway for obtaining iron from the blood circulation in the retina. However, the iron storage protein ferritin has been also recently proposed as an iron carrier. In this study, the presence of Scara5 and its binding to L-ferritin was investigated in the retina. Our results showed that Scara5, the specific receptor for L-ferritin, was expressed in mouse and human retinas in many cell types, including endothelial cells. Furthermore, we showed that intravenously injected ferritin crossed the blood retinal barrier through L-ferritin binding to Scara5 in endothelial cells. Thus, suggesting the existence of a new pathway for iron delivery and trafficking in the retina. In a murine model of photoreceptor degeneration, Scara5 was downregulated, pointing out this receptor as a potential player implicated in retinopathy and also as a possible therapeutic target.
    PLoS ONE 09/2014; 9(9):e106974. DOI:10.1371/journal.pone.0106974 · 3.53 Impact Factor

Preview (3 Sources)

Available from